Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib plasma concentration study in Chinese patients with gastrointestinal stromal tumor
ChiCTR-RNC-14004667Phase 4Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of imatinib in gastrointestinal stromal tumor (GIST), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: plasma concentration, progression-free survival and 1 more. Started Jun 2014; status: completed.
02
Drugs
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on ChiCTR-RNC-14004667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-RNC-14004667.